• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AT1

ATOMO DIAGNOSTICS LIMITED - Announcements

0.00% ! 1.9¢
Market Cap $14.96M  !

Atomo Diagnostics Limited is an Australia-based medical device company. The Company... Atomo Diagnostics Limited is an Australia-based medical device company. The Company supplies integrated rapid diagnostic test (RDT) devices to the global diagnostic market. The Company’s patented devices simplify testing procedures, enhance usability and improve reliability across rapid point-of-care (POC) and at-home testing applications. The Company has commercialized a number of products across international markets and has supply agreements in place for testing applications targeting infectious diseases, including COVID-19, HIV, viral vs bacterial differentiations as well as the early detection of pregnancy. Its products include Atomo HIV Self-Test, AtomoRapid Pascal and AtomoRapid Curie, among others. Its Atomo HIV Self-Test is an integrated, blood-based rapid diagnostic test (RDT) for HIV screening, which provides results in 15 minutes. The AtomoRapid Pascal platform offers improved performance and usability in point of care testing.More

Announcements



Filters [Clear]
  • Price Sensitive: Yes
AT1 Atomo secures order for Pascal worth US$410,000 from LumosPRICE SENSITIVE07/08/25 download Created with Sketch. 213.57KB
AT1 Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE29/07/25 download Created with Sketch. 1.54MB
AT1 Successful Placement from Share Purchase Plan ShortfallPRICE SENSITIVE21/07/25 download Created with Sketch. 183.15KB
AT1 Share Purchase Plan Results & Tranche 2 Placement ApprovedPRICE SENSITIVE27/06/25 download Created with Sketch. 184.5KB
AT1 Atomo secures Australian order for supply of HIV Self-TestsPRICE SENSITIVE27/05/25 download Created with Sketch. 145.94KB
AT1 Share Purchase Plan ProspectusPRICE SENSITIVE20/05/25 download Created with Sketch. 440.11KB
AT1 Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE24/04/25 download Created with Sketch. 1022.19KB
AT1 Atomo completes Capital Raise and undertakes RestructurePRICE SENSITIVE24/04/25 download Created with Sketch. 278.86KB
AT1 Trading HaltPRICE SENSITIVE22/04/25 download Created with Sketch. 522.44KB
AT1 National Scale up of HIV Self-Test Vending MachinesPRICE SENSITIVE07/04/25 download Created with Sketch. 134.05KB
AT1 Reinstatement to QuotationPRICE SENSITIVE24/03/25 download Created with Sketch. 420.7KB
AT1 Suspension from QuotationPRICE SENSITIVE24/03/25 download Created with Sketch. 521.72KB
AT1 Pause in TradingPRICE SENSITIVE24/03/25 download Created with Sketch. 113.6KB
AT1 H1 FY25 Results PresentationPRICE SENSITIVE28/02/25 download Created with Sketch. 1.52MB
AT1 Appendix 4D and Half Year Report ended 31 Dec 2024PRICE SENSITIVE28/02/25 download Created with Sketch. 570.63KB
AT1 Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE30/01/25 download Created with Sketch. 3.3MB
AT1 Atomo Secures Long Term Agreement with NewfoundlandPRICE SENSITIVE14/01/25 download Created with Sketch. 176.59KB
AT1 Atomo secures Australian order for supply of HIV Self-TestsPRICE SENSITIVE13/11/24 download Created with Sketch. 92.32KB
AT1 Quarterly Activities Report and Appendix 4CPRICE SENSITIVE29/10/24 download Created with Sketch. 983.86KB
AT1 Atomo Secures $2.44m Grant to Develop Syphilis TestPRICE SENSITIVE23/10/24 download Created with Sketch. 274.59KB
AT1 2024 Appendix 4E and Annual ReportPRICE SENSITIVE29/08/24 download Created with Sketch. 1.1MB
AT1 Quarterly Activities Report and Appendix 4CPRICE SENSITIVE25/07/24 download Created with Sketch. 1.03MB
AT1 Government funded procurement of Atomo HIV tests commencingPRICE SENSITIVE12/06/24 download Created with Sketch. 300.51KB
AT1 Significant funding to HIV Self-Testing in Federal BudgetPRICE SENSITIVE16/05/24 download Created with Sketch. 250.84KB
AT1 Quarterly Activities Report and Appendix 4CPRICE SENSITIVE29/04/24 download Created with Sketch. 958.52KB
AT1 AT1 secures significant order for HIV self-testsPRICE SENSITIVE15/04/24 download Created with Sketch. 135.35KB
AT1 AT1 secures significant order for HIV self tests for LMICPRICE SENSITIVE06/03/24 download Created with Sketch. 89.48KB
AT1 Appendix 4D and Half Year Report ended 31 Dec 2023PRICE SENSITIVE26/02/24 download Created with Sketch. 367.79KB
AT1 Quarterly Activity Report - 31 December 2023PRICE SENSITIVE29/01/24 download Created with Sketch. 630.28KB
AT1 Appendix 4C - 31 December 2023PRICE SENSITIVE29/01/24 download Created with Sketch. 810.62KB
AT1 Quarterly Activity Report - 30 September 2023PRICE SENSITIVE26/10/23 download Created with Sketch. 162.18KB
AT1 Appendix 4C - 30 September 2023PRICE SENSITIVE26/10/23 download Created with Sketch. 834.17KB
AT1 HIV Self-Test - Market UpdatePRICE SENSITIVE20/10/23 download Created with Sketch. 171.8KB
AT1 2023 Appendix 4E and Annual ReportPRICE SENSITIVE24/08/23 download Created with Sketch. 950.22KB
AT1 Quarterly Activity Report - 30 June 2023PRICE SENSITIVE27/07/23 download Created with Sketch. 167.68KB
AT1 Appendix 4C - 30 June 2023PRICE SENSITIVE27/07/23 download Created with Sketch. 809.78KB
AT1 Investor Presentation - Placement and SPPPRICE SENSITIVE13/07/23 download Created with Sketch. 4.54MB
AT1 Atomo Completes Placement and Launches SPPPRICE SENSITIVE13/07/23 download Created with Sketch. 203.66KB
AT1 Trading HaltPRICE SENSITIVE11/07/23 download Created with Sketch. 273.59KB
AT1 Price Movement ClarificationPRICE SENSITIVE04/07/23 download Created with Sketch. 135.31KB
AT1 Exclusive Agreement for HIV Testing Signed with NewfoundlandPRICE SENSITIVE14/06/23 download Created with Sketch. 172.81KB
AT1 Quarterly Activity Report - 31 March 2023PRICE SENSITIVE27/04/23 download Created with Sketch. 162.09KB
AT1 Appendix 4C - 31 March 2023PRICE SENSITIVE27/04/23 download Created with Sketch. 805.69KB
AT1 A$1.9m contract - South Africa HIV Self-Test private marketPRICE SENSITIVE05/04/23 download Created with Sketch. 146.89KB
AT1 Significant Purchase Order for HIV Self-Tests for EuropePRICE SENSITIVE28/02/23 download Created with Sketch. 138.77KB
AT1 Investor PresentationPRICE SENSITIVE23/02/23 download Created with Sketch. 1.18MB
AT1 Appendix 4D and Half Year Financial ReportPRICE SENSITIVE23/02/23 download Created with Sketch. 469.08KB
AT1 Quarterly Activity Report - 31 December 2022PRICE SENSITIVE27/01/23 download Created with Sketch. 194.58KB
AT1 Appendix 4C - 31 December 2022PRICE SENSITIVE27/01/23 download Created with Sketch. 831.22KB
AT1 Agreement for Rapid Pregnancy Tests Signed with NG BiotechPRICE SENSITIVE18/01/23 download Created with Sketch. 192.04KB
AT1 Quarterly Activity Report - 30 September 2022PRICE SENSITIVE25/10/22 download Created with Sketch. 167.27KB
AT1 Appendix 4C - 30 September 2022PRICE SENSITIVE25/10/22 download Created with Sketch. 809.69KB
AT1 2022 Appendix 4E and Annual ReportPRICE SENSITIVE25/08/22 download Created with Sketch. 1.25MB
AT1 Quarterly Activity Report - 30 June 2022PRICE SENSITIVE29/07/22 download Created with Sketch. 233.27KB
AT1 Appendix 4C - 30 June 2022PRICE SENSITIVE29/07/22 download Created with Sketch. 830.13KB
AT1 Quarterly Activity Report - 31 March 2022PRICE SENSITIVE27/04/22 download Created with Sketch. 198.58KB
AT1 Appendix 4C - 31 March 2022PRICE SENSITIVE27/04/22 download Created with Sketch. 874.38KB
AT1 Investor PresentationPRICE SENSITIVE21/02/22 download Created with Sketch. 1.33MB
AT1 Appendix 4D and Half Year Financial ReportPRICE SENSITIVE21/02/22 download Created with Sketch. 784.26KB
AT1 Atomo receives approval for its COVID-19 antigen test in NZPRICE SENSITIVE27/01/22 download Created with Sketch. 145.2KB
AT1 Quarterly Activity Report - 31 December 2021PRICE SENSITIVE25/01/22 download Created with Sketch. 266.99KB
AT1 Appendix 4C - 31 December 2021PRICE SENSITIVE25/01/22 download Created with Sketch. 808.99KB
AT1 Response to ASX Price QueryPRICE SENSITIVE30/12/21 download Created with Sketch. 242.7KB
AT1 HIV Self-Test - improved supply & advertising conditionsPRICE SENSITIVE26/10/21 download Created with Sketch. 124.29KB
AT1 Quarterly Activity Report - 30 September 2021PRICE SENSITIVE25/10/21 download Created with Sketch. 277.65KB
AT1 Appendix 4C - 30 September 2021PRICE SENSITIVE25/10/21 download Created with Sketch. 776.92KB
AT1 Atomo and Access Bio renegotiate supply agreementsPRICE SENSITIVE05/10/21 download Created with Sketch. 103.23KB
AT1 Trading HaltPRICE SENSITIVE04/10/21 download Created with Sketch. 193.15KB
AT1 Pause in TradingPRICE SENSITIVE04/10/21 download Created with Sketch. 117.13KB
AT1 FY21 Results PresentationPRICE SENSITIVE27/08/21 download Created with Sketch. 1.94MB
AT1 Appendix 4E & Annual Financial ReportPRICE SENSITIVE27/08/21 download Created with Sketch. 365.91KB
AT1 Quarterly Activity Report - 30 June 2021PRICE SENSITIVE29/07/21 download Created with Sketch. 316.1KB
AT1 Appendix 4C - 30 June 2021PRICE SENSITIVE29/07/21 download Created with Sketch. 874.74KB
AT1 Access Bio receives FDA clearance for COVID-19 antibody testPRICE SENSITIVE28/06/21 download Created with Sketch. 229.77KB
AT1 Update to Atomo's US market strategyPRICE SENSITIVE30/04/21 download Created with Sketch. 154.1KB
AT1 Quarterly Activity Report & Appendix 4C - 31 March 2021PRICE SENSITIVE30/04/21 download Created with Sketch. 642.38KB
AT1 Viatris & Atomo to Support Unitaid HIV Self-Test ExpansionPRICE SENSITIVE29/04/21 download Created with Sketch. 219.48KB
AT1 S&P DJI Announces March 2021 Quarterly RebalancePRICE SENSITIVE12/03/21 download Created with Sketch. 183.24KB
AT1 Investor PresentationPRICE SENSITIVE23/02/21 download Created with Sketch. 2.81MB
AT1 Appendix 4D and Half Year Financial ReportPRICE SENSITIVE23/02/21 download Created with Sketch. 675.53KB
AT1 Quarterly Activity Report & Appendix 4C - 31 December 2020PRICE SENSITIVE27/01/21 download Created with Sketch. 697.41KB
AT1 Atomo provides update on its HIV Rapid Test businessPRICE SENSITIVE07/12/20 download Created with Sketch. 369.13KB
AT1 Atomo receives TGA approval for AtomoRapid HIV (1&2) testPRICE SENSITIVE10/11/20 download Created with Sketch. 355.89KB
AT1 Managing Director's AGM PresentationPRICE SENSITIVE04/11/20 download Created with Sketch. 1.6MB
AT1 Quarterly Activity Report & Appendix 4C - 30 September 2020PRICE SENSITIVE29/10/20 download Created with Sketch. 768.95KB
AT1 Atomo receives TGA approval for COVID19 antigen testPRICE SENSITIVE27/10/20 download Created with Sketch. 527.41KB
AT1 Trading HaltPRICE SENSITIVE27/10/20 download Created with Sketch. 308.14KB
AT1 Atomo & Access Bio sign deal for rapid antigen testPRICE SENSITIVE29/09/20 download Created with Sketch. 516.59KB
AT1 Pause in TradingPRICE SENSITIVE29/09/20 download Created with Sketch. 116.08KB
AT1 DIVOC Labs to sell Atomo's COVID-19 test in IndiaPRICE SENSITIVE23/09/20 download Created with Sketch. 331.29KB
AT1 Pause in TradingPRICE SENSITIVE23/09/20 download Created with Sketch. 116.17KB
AT1 FY20 Results PresentationPRICE SENSITIVE31/08/20 download Created with Sketch. 2.2MB
AT1 Appendix 4E & Annual Financial ReportPRICE SENSITIVE31/08/20 download Created with Sketch. 4.8MB
AT1 Atomo receives TGA approval for COVID19 antibody testPRICE SENSITIVE10/08/20 download Created with Sketch. 236.93KB
AT1 Pause in TradingPRICE SENSITIVE10/08/20 download Created with Sketch. 115.95KB
AT1 Atomo & Access Bio enter North American COVID-19 partnershipPRICE SENSITIVE28/07/20 download Created with Sketch. 416.4KB
AT1 Quarterly Activity Report & Appendix 4C - 30 June 2020PRICE SENSITIVE22/07/20 download Created with Sketch. 505.42KB
AT1 S&P DJI Announces June 2020 Quarterly RebalancePRICE SENSITIVE12/06/20 download Created with Sketch. 223.16KB
AT1 Atomo and NG Biotech expand COVID-19 partnershipPRICE SENSITIVE04/06/20 download Created with Sketch. 382.44KB
AT1 Pause in TradingPRICE SENSITIVE04/06/20 download Created with Sketch. 115.52KB
AT1 Atomo secures order for Pascal worth US$410,000 from Lumos
07/08/25PRICE SENSITIVE download Created with Sketch. 213.57KB
AT1 Quarterly Activities/Appendix 4C Cash Flow Report
29/07/25PRICE SENSITIVE download Created with Sketch. 1.54MB
AT1 Successful Placement from Share Purchase Plan Shortfall
21/07/25PRICE SENSITIVE download Created with Sketch. 183.15KB
AT1 Share Purchase Plan Results & Tranche 2 Placement Approved
27/06/25PRICE SENSITIVE download Created with Sketch. 184.5KB
AT1 Atomo secures Australian order for supply of HIV Self-Tests
27/05/25PRICE SENSITIVE download Created with Sketch. 145.94KB
AT1 Share Purchase Plan Prospectus
20/05/25PRICE SENSITIVE download Created with Sketch. 440.11KB
AT1 Quarterly Activities/Appendix 4C Cash Flow Report
24/04/25PRICE SENSITIVE download Created with Sketch. 1022.19KB
AT1 Atomo completes Capital Raise and undertakes Restructure
24/04/25PRICE SENSITIVE download Created with Sketch. 278.86KB
AT1 Trading Halt
22/04/25PRICE SENSITIVE download Created with Sketch. 522.44KB
AT1 National Scale up of HIV Self-Test Vending Machines
07/04/25PRICE SENSITIVE download Created with Sketch. 134.05KB
AT1 Reinstatement to Quotation
24/03/25PRICE SENSITIVE download Created with Sketch. 420.7KB
AT1 Suspension from Quotation
24/03/25PRICE SENSITIVE download Created with Sketch. 521.72KB
AT1 Pause in Trading
24/03/25PRICE SENSITIVE download Created with Sketch. 113.6KB
AT1 H1 FY25 Results Presentation
28/02/25PRICE SENSITIVE download Created with Sketch. 1.52MB
AT1 Appendix 4D and Half Year Report ended 31 Dec 2024
28/02/25PRICE SENSITIVE download Created with Sketch. 570.63KB
AT1 Quarterly Activities/Appendix 4C Cash Flow Report
30/01/25PRICE SENSITIVE download Created with Sketch. 3.3MB
AT1 Atomo Secures Long Term Agreement with Newfoundland
14/01/25PRICE SENSITIVE download Created with Sketch. 176.59KB
AT1 Atomo secures Australian order for supply of HIV Self-Tests
13/11/24PRICE SENSITIVE download Created with Sketch. 92.32KB
AT1 Quarterly Activities Report and Appendix 4C
29/10/24PRICE SENSITIVE download Created with Sketch. 983.86KB
AT1 Atomo Secures $2.44m Grant to Develop Syphilis Test
23/10/24PRICE SENSITIVE download Created with Sketch. 274.59KB
AT1 2024 Appendix 4E and Annual Report
29/08/24PRICE SENSITIVE download Created with Sketch. 1.1MB
AT1 Quarterly Activities Report and Appendix 4C
25/07/24PRICE SENSITIVE download Created with Sketch. 1.03MB
AT1 Government funded procurement of Atomo HIV tests commencing
12/06/24PRICE SENSITIVE download Created with Sketch. 300.51KB
AT1 Significant funding to HIV Self-Testing in Federal Budget
16/05/24PRICE SENSITIVE download Created with Sketch. 250.84KB
AT1 Quarterly Activities Report and Appendix 4C
29/04/24PRICE SENSITIVE download Created with Sketch. 958.52KB
AT1 AT1 secures significant order for HIV self-tests
15/04/24PRICE SENSITIVE download Created with Sketch. 135.35KB
AT1 AT1 secures significant order for HIV self tests for LMIC
06/03/24PRICE SENSITIVE download Created with Sketch. 89.48KB
AT1 Appendix 4D and Half Year Report ended 31 Dec 2023
26/02/24PRICE SENSITIVE download Created with Sketch. 367.79KB
AT1 Quarterly Activity Report - 31 December 2023
29/01/24PRICE SENSITIVE download Created with Sketch. 630.28KB
AT1 Appendix 4C - 31 December 2023
29/01/24PRICE SENSITIVE download Created with Sketch. 810.62KB
AT1 Quarterly Activity Report - 30 September 2023
26/10/23PRICE SENSITIVE download Created with Sketch. 162.18KB
AT1 Appendix 4C - 30 September 2023
26/10/23PRICE SENSITIVE download Created with Sketch. 834.17KB
AT1 HIV Self-Test - Market Update
20/10/23PRICE SENSITIVE download Created with Sketch. 171.8KB
AT1 2023 Appendix 4E and Annual Report
24/08/23PRICE SENSITIVE download Created with Sketch. 950.22KB
AT1 Quarterly Activity Report - 30 June 2023
27/07/23PRICE SENSITIVE download Created with Sketch. 167.68KB
AT1 Appendix 4C - 30 June 2023
27/07/23PRICE SENSITIVE download Created with Sketch. 809.78KB
AT1 Investor Presentation - Placement and SPP
13/07/23PRICE SENSITIVE download Created with Sketch. 4.54MB
AT1 Atomo Completes Placement and Launches SPP
13/07/23PRICE SENSITIVE download Created with Sketch. 203.66KB
AT1 Trading Halt
11/07/23PRICE SENSITIVE download Created with Sketch. 273.59KB
AT1 Price Movement Clarification
04/07/23PRICE SENSITIVE download Created with Sketch. 135.31KB
AT1 Exclusive Agreement for HIV Testing Signed with Newfoundland
14/06/23PRICE SENSITIVE download Created with Sketch. 172.81KB
AT1 Quarterly Activity Report - 31 March 2023
27/04/23PRICE SENSITIVE download Created with Sketch. 162.09KB
AT1 Appendix 4C - 31 March 2023
27/04/23PRICE SENSITIVE download Created with Sketch. 805.69KB
AT1 A$1.9m contract - South Africa HIV Self-Test private market
05/04/23PRICE SENSITIVE download Created with Sketch. 146.89KB
AT1 Significant Purchase Order for HIV Self-Tests for Europe
28/02/23PRICE SENSITIVE download Created with Sketch. 138.77KB
AT1 Investor Presentation
23/02/23PRICE SENSITIVE download Created with Sketch. 1.18MB
AT1 Appendix 4D and Half Year Financial Report
23/02/23PRICE SENSITIVE download Created with Sketch. 469.08KB
AT1 Quarterly Activity Report - 31 December 2022
27/01/23PRICE SENSITIVE download Created with Sketch. 194.58KB
AT1 Appendix 4C - 31 December 2022
27/01/23PRICE SENSITIVE download Created with Sketch. 831.22KB
AT1 Agreement for Rapid Pregnancy Tests Signed with NG Biotech
18/01/23PRICE SENSITIVE download Created with Sketch. 192.04KB
AT1 Quarterly Activity Report - 30 September 2022
25/10/22PRICE SENSITIVE download Created with Sketch. 167.27KB
AT1 Appendix 4C - 30 September 2022
25/10/22PRICE SENSITIVE download Created with Sketch. 809.69KB
AT1 2022 Appendix 4E and Annual Report
25/08/22PRICE SENSITIVE download Created with Sketch. 1.25MB
AT1 Quarterly Activity Report - 30 June 2022
29/07/22PRICE SENSITIVE download Created with Sketch. 233.27KB
AT1 Appendix 4C - 30 June 2022
29/07/22PRICE SENSITIVE download Created with Sketch. 830.13KB
AT1 Quarterly Activity Report - 31 March 2022
27/04/22PRICE SENSITIVE download Created with Sketch. 198.58KB
AT1 Appendix 4C - 31 March 2022
27/04/22PRICE SENSITIVE download Created with Sketch. 874.38KB
AT1 Investor Presentation
21/02/22PRICE SENSITIVE download Created with Sketch. 1.33MB
AT1 Appendix 4D and Half Year Financial Report
21/02/22PRICE SENSITIVE download Created with Sketch. 784.26KB
AT1 Atomo receives approval for its COVID-19 antigen test in NZ
27/01/22PRICE SENSITIVE download Created with Sketch. 145.2KB
AT1 Quarterly Activity Report - 31 December 2021
25/01/22PRICE SENSITIVE download Created with Sketch. 266.99KB
AT1 Appendix 4C - 31 December 2021
25/01/22PRICE SENSITIVE download Created with Sketch. 808.99KB
AT1 Response to ASX Price Query
30/12/21PRICE SENSITIVE download Created with Sketch. 242.7KB
AT1 HIV Self-Test - improved supply & advertising conditions
26/10/21PRICE SENSITIVE download Created with Sketch. 124.29KB
AT1 Quarterly Activity Report - 30 September 2021
25/10/21PRICE SENSITIVE download Created with Sketch. 277.65KB
AT1 Appendix 4C - 30 September 2021
25/10/21PRICE SENSITIVE download Created with Sketch. 776.92KB
AT1 Atomo and Access Bio renegotiate supply agreements
05/10/21PRICE SENSITIVE download Created with Sketch. 103.23KB
AT1 Trading Halt
04/10/21PRICE SENSITIVE download Created with Sketch. 193.15KB
AT1 Pause in Trading
04/10/21PRICE SENSITIVE download Created with Sketch. 117.13KB
AT1 FY21 Results Presentation
27/08/21PRICE SENSITIVE download Created with Sketch. 1.94MB
AT1 Appendix 4E & Annual Financial Report
27/08/21PRICE SENSITIVE download Created with Sketch. 365.91KB
AT1 Quarterly Activity Report - 30 June 2021
29/07/21PRICE SENSITIVE download Created with Sketch. 316.1KB
AT1 Appendix 4C - 30 June 2021
29/07/21PRICE SENSITIVE download Created with Sketch. 874.74KB
AT1 Access Bio receives FDA clearance for COVID-19 antibody test
28/06/21PRICE SENSITIVE download Created with Sketch. 229.77KB
AT1 Update to Atomo's US market strategy
30/04/21PRICE SENSITIVE download Created with Sketch. 154.1KB
AT1 Quarterly Activity Report & Appendix 4C - 31 March 2021
30/04/21PRICE SENSITIVE download Created with Sketch. 642.38KB
AT1 Viatris & Atomo to Support Unitaid HIV Self-Test Expansion
29/04/21PRICE SENSITIVE download Created with Sketch. 219.48KB
AT1 S&P DJI Announces March 2021 Quarterly Rebalance
12/03/21PRICE SENSITIVE download Created with Sketch. 183.24KB
AT1 Investor Presentation
23/02/21PRICE SENSITIVE download Created with Sketch. 2.81MB
AT1 Appendix 4D and Half Year Financial Report
23/02/21PRICE SENSITIVE download Created with Sketch. 675.53KB
AT1 Quarterly Activity Report & Appendix 4C - 31 December 2020
27/01/21PRICE SENSITIVE download Created with Sketch. 697.41KB
AT1 Atomo provides update on its HIV Rapid Test business
07/12/20PRICE SENSITIVE download Created with Sketch. 369.13KB
AT1 Atomo receives TGA approval for AtomoRapid HIV (1&2) test
10/11/20PRICE SENSITIVE download Created with Sketch. 355.89KB
AT1 Managing Director's AGM Presentation
04/11/20PRICE SENSITIVE download Created with Sketch. 1.6MB
AT1 Quarterly Activity Report & Appendix 4C - 30 September 2020
29/10/20PRICE SENSITIVE download Created with Sketch. 768.95KB
AT1 Atomo receives TGA approval for COVID19 antigen test
27/10/20PRICE SENSITIVE download Created with Sketch. 527.41KB
AT1 Trading Halt
27/10/20PRICE SENSITIVE download Created with Sketch. 308.14KB
AT1 Atomo & Access Bio sign deal for rapid antigen test
29/09/20PRICE SENSITIVE download Created with Sketch. 516.59KB
AT1 Pause in Trading
29/09/20PRICE SENSITIVE download Created with Sketch. 116.08KB
AT1 DIVOC Labs to sell Atomo's COVID-19 test in India
23/09/20PRICE SENSITIVE download Created with Sketch. 331.29KB
AT1 Pause in Trading
23/09/20PRICE SENSITIVE download Created with Sketch. 116.17KB
AT1 FY20 Results Presentation
31/08/20PRICE SENSITIVE download Created with Sketch. 2.2MB
AT1 Appendix 4E & Annual Financial Report
31/08/20PRICE SENSITIVE download Created with Sketch. 4.8MB
AT1 Atomo receives TGA approval for COVID19 antibody test
10/08/20PRICE SENSITIVE download Created with Sketch. 236.93KB
AT1 Pause in Trading
10/08/20PRICE SENSITIVE download Created with Sketch. 115.95KB
AT1 Atomo & Access Bio enter North American COVID-19 partnership
28/07/20PRICE SENSITIVE download Created with Sketch. 416.4KB
AT1 Quarterly Activity Report & Appendix 4C - 30 June 2020
22/07/20PRICE SENSITIVE download Created with Sketch. 505.42KB
AT1 S&P DJI Announces June 2020 Quarterly Rebalance
12/06/20PRICE SENSITIVE download Created with Sketch. 223.16KB
AT1 Atomo and NG Biotech expand COVID-19 partnership
04/06/20PRICE SENSITIVE download Created with Sketch. 382.44KB
AT1 Pause in Trading
04/06/20PRICE SENSITIVE download Created with Sketch. 115.52KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.9¢
Change
0.000(0.00%)
Mkt cap ! $14.96M
Open High Low Value Volume
2.0¢ 2.0¢ 1.9¢ $10.62K 558.0K

Buyers (Bids)

No. Vol. Price($)
4 733214 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 1314428 4
View Market Depth
Last trade - 13.55pm 11/08/2025 (20 minute delay) ?
Last
1.9¢
  Change
0.000 ( 5.00 %)
Open High Low Volume
1.9¢ 2.0¢ 1.9¢ 417165
Last updated 15.59pm 11/08/2025 ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.